We would love to hear your thoughts about our site and services, please take our survey here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksReckitt Regulatory News (RKT)

Share Price Information for Reckitt (RKT)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 4,250.00
Bid: 4,263.00
Ask: 4,265.00
Change: -16.00 (-0.38%)
Spread: 2.00 (0.047%)
Open: 4,286.00
High: 4,302.00
Low: 4,244.00
Prev. Close: 4,266.00
RKT Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Annual Financial Report

14 Apr 2022 12:26

RNS Number : 4442I
Reckitt Benckiser Group PLC
14 April 2022
 

14 April 2022

 

RECKITT BENCKISER GROUP PLC

("Reckitt" or the "Company")

 

2021 Annual Report and Directorate Change

 

The Company announces that it has today published its Annual Report and Accounts for the year ended 31 December 2021 (the '2021 Annual Report') on the Company's website, www.reckitt.com.

 

In accordance with Listing Rule 9.6.1, a copy of the Annual Report has been submitted to the National Storage Mechanism and will shortly be available to view at https://data.fca.org.uk/#/nsm/nationalstoragemechanism.

 

In conformity with DTR 6.3.5(1A) the regulated information required under DTR 6.3.5 is available in unedited full text within the 2021 Annual Report as uploaded and available on the National Storage Mechanism and on the Company's website as noted above.

 

The Company's Annual General Meeting will be held at 2pm on Friday 20 May 2022, at the London Heathrow Marriott Hotel, Bath Road, Hayes UB3 5AN. The 2021 Annual Report together with the Notice of AGM and Form of Proxy will be mailed or otherwise made available to shareholders in due course.

 

Directorate change

 

Sara Mathew has notified the Company that she does not intend to seek re-election as a Non-Executive Director at the Company's Annual General Meeting to be held on 20 May 2022. Sara has been a member of the Board and Audit Committee since July 2019.

 

Chris Sinclair, Chairman of the Board, commented "Sara has been a valuable member of the Board and Audit Committee and brought great insight to Board discussions. We would like to thank her for her significant contribution".

 

This disclosure is made in accordance with Listing Rule 9.6.11(3).

 

 

For further Information:Catheryn O'Rourke

Company Secretary

Tel +44 (0) 1753 217 800

 

Richard Joyce

Head of Investor Relations

Tel +44 (0) 7408 812 062

 

Reckitt Benckiser Group plc's LEI code is 5493003JFSMOJG48V108

  

About Reckitt:

 

Reckitt* exists to protect, heal and nurture in the relentless pursuit of a cleaner, healthier world. We believe that access to the highest-quality hygiene, wellness and nourishment is a right, not a privilege.

 

Reckitt is the company behind some of the world's most recognisable and trusted consumer brands in hygiene, health and nutrition, including Air Wick, Calgon, Cillit Bang, Clearasil, Dettol, Durex, Enfamil, Finish, Gaviscon, Harpic, Lysol, Mortein, Mucinex, Nurofen, Nutramigen, Strepsils, Vanish, Veet, Woolite and more.

 

Every day, more than 20 million Reckitt products are bought globally. We always put consumers and people first, seek out new opportunities, strive for excellence in all that we do and build shared success with all our partners. We aim to do the right thing, always.

 

We are a diverse global team of more than 43,000 colleagues. We draw on our collective energy to meet our ambitions of purpose-led brands, a healthier planet and a fairer society. Find out more, or get in touch with us at www.reckitt.com

 

*Reckitt is the trading name of the Reckitt Benckiser group of companies

 

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
ACSSFIFFLEESEEL
Date   Source Headline
23rd Apr 20247:00 amRNSTransaction in Own Shares
22nd Apr 20247:00 amRNSTransaction in Own Shares
19th Apr 20247:00 amRNSTransaction in Own Shares
18th Apr 20247:00 amRNSTransaction in Own Shares
17th Apr 20247:00 amRNSTransaction in Own Shares
16th Apr 20247:00 amRNSTransaction in Own Shares
15th Apr 20247:00 amRNSTransaction in Own Shares
12th Apr 20247:00 amRNSTransaction in Own Shares
11th Apr 20247:00 amRNSTransaction in Own Shares
10th Apr 20247:00 amRNSTransaction in Own Shares
9th Apr 20247:00 amRNSTransaction in Own Shares
8th Apr 20247:00 amRNSTransaction in Own Shares
5th Apr 202410:00 amRNSAnnual Financial Report
4th Apr 202410:15 amRNSShare Buyback Programme - Third Tranche
4th Apr 20247:00 amRNSTransaction in Own Shares
3rd Apr 20247:00 amRNSTransaction in Own Shares
2nd Apr 202410:21 amRNSTotal Voting Rights
2nd Apr 20247:00 amRNSTransaction in Own Shares
28th Mar 20247:00 amRNSTransaction in Own Shares
27th Mar 20243:00 pmRNSDirector Declaration
27th Mar 202411:30 amRNSDirector/PDMR Shareholding
27th Mar 20247:00 amRNSShare Buyback Programme - Third Tranche
27th Mar 20247:00 amRNSTransaction in Own Shares
26th Mar 20244:00 pmRNSDirector/PDMR Shareholding
26th Mar 20244:00 pmRNSDirector/PDMR Shareholding
26th Mar 20247:00 amRNSTransaction in Own Shares
25th Mar 20247:00 amRNSTransaction in Own Shares
22nd Mar 20247:00 amRNSTransaction in Own Shares
21st Mar 20244:00 pmRNSDirector/PDMR Shareholding
21st Mar 20247:00 amRNSTransaction in Own Shares
20th Mar 20247:00 amRNSTransaction in Own Shares
19th Mar 20247:00 amRNSTransaction in Own Shares
18th Mar 20247:01 amRNSTransaction in Own Shares
18th Mar 20247:00 amRNSReplacement - Transaction in Own Shares
15th Mar 20243:44 pmRNSStatement re NEC Litigation
15th Mar 20247:00 amRNSTransaction in Own Shares
14th Mar 20247:00 amRNSTransaction in Own Shares
13th Mar 20247:00 amRNSTransaction in Own Shares
12th Mar 20247:00 amRNSTransaction in Own Shares
11th Mar 20247:00 amRNSTransaction in Own Shares
8th Mar 20247:00 amRNSTransaction in Own Shares
7th Mar 20243:30 pmRNSDirector/PDMR Shareholding
7th Mar 202411:00 amRNSDirector/PDMR Shareholding
7th Mar 20247:00 amRNSTransaction in Own Shares
6th Mar 20247:00 amRNSTransaction in Own Shares
5th Mar 20247:00 amRNSTransaction in Own Shares
4th Mar 20247:00 amRNSTransaction in Own Shares
1st Mar 202411:34 amRNSTotal Voting Rights
1st Mar 20247:00 amRNSTransaction in Own Shares
29th Feb 20247:00 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.